Hepatic hemangioma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatic hemangioma}} | {{Hepatic hemangioma}} | ||
{{CMG}} | {{CMG}};{{AE}}{{NM}} | ||
==Overview== | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
Revision as of 13:54, 20 October 2015
|
Hepatic hemangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatic hemangioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hepatic hemangioma epidemiology and demographics |
|
Hepatic hemangioma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Hepatic hemangioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence ranges from 0.4-20% of the population.
Age
- Hepatic hemangiomas can occur at any time, but are most common in people in their 30s - 50s.
Gender
- Women are affected more often than men (5:1), and usually have bigger tumors than men.